These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1511801)

  • 1. Autoantibodies to 64,000-M(r) islet cell protein in long-term type 1 (insulin-dependent) diabetic patients.
    Kawasaki E; Moriuchi R; Takino H; Okuno S; Takao Y; Maeda Y; Yokota A; Yamamoto H; Chikuba N; Akazawa S
    Diabetologia; 1992 Aug; 35(8):748-52. PubMed ID: 1511801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to glutamic acid decarboxylase (GAD), 64,000-Mr islet cell protein (64K) antibodies and islet cell antibodies (ICA) in insulin-dependent diabetes mellitus with and without autoimmune diseases in Japan.
    Akawaza S; Kawasaki E; Yano M; Abiru N; Yamaguchi Y; Nagataki S
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S89-93. PubMed ID: 7859640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Takao Y; Yamaguchi Y; Akazawa S; Nagataki S
    Diabetes; 1994 Jan; 43(1):80-6. PubMed ID: 8262321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
    Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
    Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.
    Bärmeier H; McCulloch DK; Neifing JL; Warnock G; Rajotte RV; Palmer JP; Lernmark A
    Diabetologia; 1991 Oct; 34(10):727-33. PubMed ID: 1959705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM.
    Chaillous L; Delamaire M; Elmansour A; Maugendre D; Rohmer V; Joseph MG; Lecomte P; Limal JM; Charbonnel B; Allannic H
    Diabetologia; 1994 May; 37(5):491-9. PubMed ID: 8056187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to the M(r) 64,000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired beta-cell function.
    Seissler J; Hering B; Richter W; Glück M; Yassin N; Bretzel RG; Boehm BO; Federlin K; Scherbaum WA
    Diabetologia; 1992 Jun; 35(6):550-4. PubMed ID: 1612228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are zinc transporter type 8 antibodies a marker of autoimmune thyroiditis in non-obese adults with new-onset diabetes?
    Rogowicz-Frontczak A; Zozuliłska-Ziołkiewicz D; Litwinowicz M; Niedźwiecki P; Wyka K; Wierusz-Wysocka B
    Eur J Endocrinol; 2014 Apr; 170(4):651-8. PubMed ID: 24480135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
    Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
    J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals.
    Thivolet CH; Tappaz M; Durand A; Petersen J; Stefanutti A; Chatelain P; Vialettes B; Scherbaum W; Orgiazzi J
    Diabetologia; 1992 Jun; 35(6):570-6. PubMed ID: 1612231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heterogeneity of whole islet cell cytoplasmic antibodies evidenced by absorption test with glutamic acid decarboxylase.
    Takino H; Kawasaki E; Yano M; Matsumoto K; Uotani S; Okuno S; Takao Y; Yamasaki H; Yamaguchi Y; Akazawa S
    J Autoimmun; 1994 Jun; 7(3):389-98. PubMed ID: 7916910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study.
    Verge CF; Howard NJ; Rowley MJ; Mackay IR; Zimmet PZ; Egan M; Hulinska H; Hulinsky I; Silvestrini RA; Kamath S
    Diabetologia; 1994 Nov; 37(11):1113-20. PubMed ID: 7867883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity among patients with latent autoimmune diabetes in adults.
    Maruyama T; Nakagawa T; Kasuga A; Murata M
    Diabetes Metab Res Rev; 2011 Nov; 27(8):971-4. PubMed ID: 22069295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies.
    Kawasaki E; Abiru N; Yano M; Uotani S; Matsumoto K; Matsuo H; Yamasaki H; Yamamoto H; Yamaguchi Y; Akazawa S
    J Autoimmun; 1995 Oct; 8(5):633-43. PubMed ID: 8579720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic characteristics of patients with autoimmune thyroid disease with anti-islet autoimmunity.
    Moriguchi M; Noso S; Kawabata Y; Yamauchi T; Harada T; Komaki K; Babaya N; Hiromine Y; Ito H; Yamagata S; Murata K; Higashimoto T; Park C; Yamamoto A; Ohno Y; Ikegami H
    Metabolism; 2011 Jun; 60(6):761-6. PubMed ID: 20825955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase.
    Baekkeskov S; Aanstoot HJ; Christgau S; Reetz A; Solimena M; Cascalho M; Folli F; Richter-Olesen H; De Camilli P
    Nature; 1990 Sep; 347(6289):151-6. PubMed ID: 1697648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic complications in adult patients with newly diagnosed diabetes mellitus in relation to the presence of humoral autoimmune markers against pancreatic islet cells].
    Szepietowska B; Szelachowska M; Górska M; Jakubczyk D; Kinalska I
    Pol Arch Med Wewn; 2004 May; 111(5):563-9. PubMed ID: 15508807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet cell antibodies in patients with autoimmune thyroid disease.
    Yamaguchi Y; Chikuba N; Ueda Y; Yamamoto H; Yamasaki H; Nakanishi T; Akazawa S; Nagataki S
    Diabetes; 1991 Mar; 40(3):319-22. PubMed ID: 1999272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of anti-islet autoantibodies in Japanese patients with type 1 diabetes.
    Horie I; Kawasaki E; Shimomura A; Satoh T; Ueki I; Kuwahara H; Ando T; Abiru N; Usa T; Eguchi K
    Endocr J; 2010; 57(7):623-8. PubMed ID: 20505260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.